Clinical Trial Update: Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab in combination with S-1 and cisplatin in gastric cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• ERBITUX (cetuximab)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-11-20